Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft vs Host Disease | 33 | 2023 | 2957 | 4.080 |
Why?
|
Hematopoietic Stem Cell Transplantation | 37 | 2023 | 5442 | 3.230 |
Why?
|
Sirolimus | 12 | 2020 | 1564 | 1.590 |
Why?
|
Macaca mulatta | 22 | 2023 | 2375 | 1.440 |
Why?
|
Bone Marrow Transplantation | 16 | 2023 | 2765 | 1.420 |
Why?
|
T-Lymphocytes, Regulatory | 11 | 2023 | 2988 | 1.400 |
Why?
|
Chimerism | 5 | 2021 | 158 | 1.290 |
Why?
|
T-Lymphocytes | 14 | 2021 | 10180 | 1.240 |
Why?
|
Transplantation Chimera | 5 | 2016 | 612 | 1.180 |
Why?
|
Anemia, Sickle Cell | 9 | 2020 | 1018 | 1.050 |
Why?
|
Transplantation Conditioning | 13 | 2023 | 1598 | 1.020 |
Why?
|
Immunosuppressive Agents | 11 | 2023 | 4149 | 0.990 |
Why?
|
Virus Activation | 2 | 2016 | 319 | 0.940 |
Why?
|
Major Histocompatibility Complex | 3 | 2018 | 936 | 0.880 |
Why?
|
Transplantation Tolerance | 6 | 2016 | 617 | 0.870 |
Why?
|
Graft Rejection | 9 | 2021 | 4397 | 0.860 |
Why?
|
Transplantation, Homologous | 16 | 2023 | 4776 | 0.820 |
Why?
|
Lymphocyte Activation | 9 | 2022 | 5524 | 0.820 |
Why?
|
Cytomegalovirus | 2 | 2016 | 732 | 0.780 |
Why?
|
Cell Tracking | 1 | 2022 | 145 | 0.750 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2023 | 570 | 0.740 |
Why?
|
Cytomegalovirus Infections | 3 | 2016 | 820 | 0.720 |
Why?
|
Receptors, Antigen, T-Cell | 5 | 2022 | 2540 | 0.720 |
Why?
|
Skin Transplantation | 3 | 2016 | 1074 | 0.710 |
Why?
|
Immunoconjugates | 4 | 2014 | 901 | 0.710 |
Why?
|
Tacrolimus | 4 | 2023 | 743 | 0.670 |
Why?
|
Hematologic Neoplasms | 5 | 2023 | 1832 | 0.660 |
Why?
|
Disease Reservoirs | 1 | 2018 | 131 | 0.640 |
Why?
|
Immunotherapy, Adoptive | 5 | 2021 | 1270 | 0.640 |
Why?
|
Interleukin-2 | 3 | 2023 | 1904 | 0.630 |
Why?
|
OX40 Ligand | 1 | 2017 | 51 | 0.620 |
Why?
|
Organ Transplantation | 3 | 2017 | 1139 | 0.620 |
Why?
|
Hematology | 1 | 2021 | 221 | 0.610 |
Why?
|
Adoptive Transfer | 3 | 2021 | 844 | 0.600 |
Why?
|
Simian immunodeficiency virus | 3 | 2020 | 846 | 0.560 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2021 | 4479 | 0.550 |
Why?
|
Virus Latency | 3 | 2014 | 358 | 0.540 |
Why?
|
Antisickling Agents | 2 | 2019 | 80 | 0.540 |
Why?
|
Rhadinovirus | 2 | 2013 | 37 | 0.540 |
Why?
|
Hydroxyurea | 2 | 2019 | 290 | 0.500 |
Why?
|
Immune Tolerance | 6 | 2022 | 2258 | 0.480 |
Why?
|
Hematologic Diseases | 1 | 2018 | 498 | 0.480 |
Why?
|
T-Lymphocyte Subsets | 2 | 2022 | 1838 | 0.480 |
Why?
|
Busulfan | 6 | 2019 | 263 | 0.470 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 4 | 2020 | 310 | 0.440 |
Why?
|
Animals | 50 | 2023 | 168757 | 0.430 |
Why?
|
Histocompatibility | 3 | 2016 | 330 | 0.420 |
Why?
|
Immunogenetics | 1 | 2011 | 67 | 0.410 |
Why?
|
Killer Cells, Natural | 4 | 2019 | 2133 | 0.410 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2016 | 1821 | 0.390 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 805 | 0.390 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2016 | 986 | 0.380 |
Why?
|
Immunophenotyping | 7 | 2020 | 1880 | 0.380 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2011 | 227 | 0.370 |
Why?
|
Heterocyclic Compounds | 1 | 2011 | 249 | 0.370 |
Why?
|
Interleukin-17 | 1 | 2016 | 899 | 0.370 |
Why?
|
Flow Cytometry | 10 | 2020 | 5974 | 0.360 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 518 | 0.350 |
Why?
|
Graft Survival | 7 | 2016 | 3737 | 0.350 |
Why?
|
Kidney Transplantation | 3 | 2014 | 4251 | 0.330 |
Why?
|
Blood Transfusion | 1 | 2015 | 1301 | 0.320 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2109 | 0.320 |
Why?
|
Leukocytes | 2 | 2021 | 2043 | 0.310 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18029 | 0.310 |
Why?
|
HLA Antigens | 2 | 2012 | 1381 | 0.300 |
Why?
|
Spleen | 4 | 2022 | 2362 | 0.300 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2007 | 130 | 0.300 |
Why?
|
Cyclophosphamide | 3 | 2023 | 2242 | 0.280 |
Why?
|
Antigens, Ly | 1 | 2007 | 291 | 0.280 |
Why?
|
Models, Animal | 2 | 2019 | 2171 | 0.280 |
Why?
|
Isoantibodies | 3 | 2015 | 679 | 0.270 |
Why?
|
Cell Proliferation | 4 | 2017 | 10481 | 0.260 |
Why?
|
Antibodies, Monoclonal | 3 | 2018 | 9274 | 0.260 |
Why?
|
Erythrocyte Transfusion | 3 | 2015 | 565 | 0.250 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2014 | 4386 | 0.250 |
Why?
|
Methotrexate | 3 | 2023 | 1727 | 0.240 |
Why?
|
Lectins, C-Type | 1 | 2007 | 588 | 0.240 |
Why?
|
Acute Disease | 4 | 2021 | 7149 | 0.240 |
Why?
|
Immunotherapy | 2 | 2023 | 4445 | 0.220 |
Why?
|
Pancytopenia | 1 | 2023 | 104 | 0.210 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2018 | 570 | 0.210 |
Why?
|
Leishmaniasis | 1 | 2022 | 47 | 0.210 |
Why?
|
Mice, Inbred BALB C | 8 | 2021 | 6386 | 0.210 |
Why?
|
Leishmania | 1 | 2022 | 64 | 0.210 |
Why?
|
Lymphocyte Depletion | 3 | 2016 | 608 | 0.200 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2022 | 517 | 0.200 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2002 | 91 | 0.200 |
Why?
|
Leishmaniasis, Visceral | 1 | 2022 | 94 | 0.200 |
Why?
|
Retinoid X Receptors | 1 | 2021 | 93 | 0.200 |
Why?
|
Herpesvirus 4, Human | 2 | 2023 | 1041 | 0.200 |
Why?
|
Receptors, Immunologic | 1 | 2007 | 1423 | 0.190 |
Why?
|
Leukapheresis | 3 | 2011 | 131 | 0.190 |
Why?
|
Bronchiolitis Obliterans | 1 | 2022 | 192 | 0.190 |
Why?
|
Phosphatidylserines | 1 | 2002 | 193 | 0.190 |
Why?
|
Graft vs Leukemia Effect | 1 | 2021 | 111 | 0.190 |
Why?
|
Primates | 3 | 2023 | 545 | 0.190 |
Why?
|
Drug Synergism | 2 | 2017 | 1792 | 0.190 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 2 | 2011 | 52 | 0.180 |
Why?
|
beta-Thalassemia | 1 | 2002 | 225 | 0.180 |
Why?
|
Cyclopropanes | 1 | 2021 | 416 | 0.170 |
Why?
|
Germinal Center | 1 | 2022 | 377 | 0.170 |
Why?
|
Herpesviridae Infections | 2 | 2013 | 277 | 0.170 |
Why?
|
Gene Expression Profiling | 2 | 2022 | 9438 | 0.170 |
Why?
|
Tretinoin | 1 | 2022 | 517 | 0.170 |
Why?
|
Transplants | 1 | 2021 | 209 | 0.170 |
Why?
|
Immunity | 2 | 2017 | 1012 | 0.170 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1607 | 0.170 |
Why?
|
Humans | 51 | 2023 | 744343 | 0.160 |
Why?
|
Half-Life | 2 | 2014 | 661 | 0.160 |
Why?
|
Thrombotic Microangiopathies | 1 | 2020 | 132 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 225 | 0.160 |
Why?
|
Forkhead Transcription Factors | 3 | 2021 | 1613 | 0.160 |
Why?
|
Antigens, CD19 | 2 | 2018 | 380 | 0.160 |
Why?
|
Phospholipids | 1 | 2002 | 784 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2012 | 1620 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.160 |
Why?
|
Erythrocytes | 2 | 2011 | 2455 | 0.160 |
Why?
|
Cyclosporine | 1 | 2021 | 786 | 0.160 |
Why?
|
Erythropoiesis | 1 | 2002 | 705 | 0.160 |
Why?
|
Child | 17 | 2023 | 77709 | 0.150 |
Why?
|
Leukocytes, Mononuclear | 4 | 2023 | 1836 | 0.150 |
Why?
|
Mice | 20 | 2023 | 81183 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 2 | 2017 | 3772 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2020 | 373 | 0.150 |
Why?
|
Antigens, CD20 | 1 | 2018 | 199 | 0.150 |
Why?
|
Goblet Cells | 1 | 2020 | 287 | 0.150 |
Why?
|
Gene Expression Regulation | 2 | 2022 | 12072 | 0.150 |
Why?
|
Leukemia | 2 | 2023 | 1511 | 0.140 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 21827 | 0.140 |
Why?
|
Kynurenine | 1 | 2017 | 139 | 0.140 |
Why?
|
Leukocyte Count | 2 | 2015 | 1588 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2022 | 3597 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2020 | 1035 | 0.140 |
Why?
|
Membrane Glycoproteins | 1 | 2007 | 3768 | 0.140 |
Why?
|
Interferon Type I | 1 | 2020 | 542 | 0.140 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2019 | 1369 | 0.140 |
Why?
|
Transplantation, Autologous | 3 | 2018 | 2124 | 0.140 |
Why?
|
Haplorhini | 1 | 2016 | 552 | 0.130 |
Why?
|
Transgenes | 1 | 2019 | 1009 | 0.130 |
Why?
|
H-Y Antigen | 1 | 2015 | 45 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.130 |
Why?
|
Tryptophan | 1 | 2017 | 478 | 0.130 |
Why?
|
Tissue Donors | 2 | 2023 | 2240 | 0.130 |
Why?
|
Adolescent | 12 | 2023 | 85781 | 0.130 |
Why?
|
Succinimides | 1 | 2014 | 79 | 0.130 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 260 | 0.120 |
Why?
|
Systems Biology | 1 | 2018 | 469 | 0.120 |
Why?
|
Transplantation Immunology | 1 | 2016 | 546 | 0.120 |
Why?
|
Fluoresceins | 1 | 2014 | 235 | 0.120 |
Why?
|
Young Adult | 11 | 2023 | 56430 | 0.120 |
Why?
|
Neurotoxicity Syndromes | 1 | 2018 | 290 | 0.120 |
Why?
|
HIV Reverse Transcriptase | 1 | 2014 | 213 | 0.120 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2020 | 1873 | 0.110 |
Why?
|
Mycobacterium tuberculosis | 2 | 2021 | 1832 | 0.110 |
Why?
|
Immunomodulation | 1 | 2017 | 541 | 0.110 |
Why?
|
Histocompatibility Testing | 2 | 2023 | 741 | 0.110 |
Why?
|
Antibodies | 2 | 2016 | 2460 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2017 | 810 | 0.110 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2015 | 314 | 0.110 |
Why?
|
Postoperative Complications | 2 | 2014 | 15295 | 0.110 |
Why?
|
RNA, Viral | 2 | 2018 | 2902 | 0.110 |
Why?
|
Antigens, CD | 3 | 2012 | 4026 | 0.110 |
Why?
|
Dendritic Cells | 2 | 2017 | 2725 | 0.100 |
Why?
|
Up-Regulation | 2 | 2020 | 4217 | 0.100 |
Why?
|
DNA, Viral | 1 | 2018 | 2225 | 0.100 |
Why?
|
Neoplasms | 2 | 2019 | 21683 | 0.100 |
Why?
|
Muramidase | 1 | 2011 | 174 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11524 | 0.090 |
Why?
|
Benzylamines | 1 | 2011 | 223 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2014 | 2327 | 0.090 |
Why?
|
Male | 19 | 2021 | 350118 | 0.090 |
Why?
|
Signal Transduction | 5 | 2023 | 23403 | 0.090 |
Why?
|
Melphalan | 2 | 2023 | 431 | 0.090 |
Why?
|
Lymphocyte Count | 1 | 2011 | 793 | 0.090 |
Why?
|
B-Lymphocytes | 2 | 2022 | 4665 | 0.080 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2015 | 1366 | 0.080 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2011 | 648 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2002 | 5021 | 0.080 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 2382 | 0.080 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2008 | 71 | 0.080 |
Why?
|
Cytokines | 3 | 2017 | 7322 | 0.080 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2007 | 30 | 0.080 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily A | 1 | 2007 | 21 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2016 | 880 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1912 | 0.080 |
Why?
|
Survival Analysis | 2 | 2018 | 10252 | 0.080 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2007 | 57 | 0.080 |
Why?
|
Mice, Inbred DBA | 2 | 2011 | 642 | 0.080 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2007 | 91 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2020 | 19229 | 0.070 |
Why?
|
Crohn Disease | 1 | 2020 | 2303 | 0.070 |
Why?
|
Immune System | 1 | 2012 | 805 | 0.070 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.070 |
Why?
|
Perforin | 1 | 2007 | 168 | 0.070 |
Why?
|
Autoimmunity | 2 | 2022 | 1349 | 0.070 |
Why?
|
Proteins | 1 | 2022 | 6103 | 0.070 |
Why?
|
Adult | 11 | 2023 | 214055 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1917 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 726 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3843 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3386 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2013 | 3144 | 0.070 |
Why?
|
Gene Expression | 2 | 2019 | 7799 | 0.070 |
Why?
|
Immunologic Memory | 2 | 2015 | 1348 | 0.070 |
Why?
|
Chronic Disease | 4 | 2023 | 9146 | 0.070 |
Why?
|
Female | 17 | 2021 | 380194 | 0.070 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 795 | 0.070 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2010 | 632 | 0.070 |
Why?
|
Connexins | 1 | 2007 | 357 | 0.070 |
Why?
|
Pain | 1 | 2020 | 4986 | 0.060 |
Why?
|
Receptors, Interleukin-2 | 1 | 2007 | 573 | 0.060 |
Why?
|
Cell Transplantation | 1 | 2007 | 477 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2002 | 7880 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1855 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2016 | 2513 | 0.060 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1715 | 0.060 |
Why?
|
Haplotypes | 1 | 2010 | 2779 | 0.060 |
Why?
|
Inflammation | 3 | 2023 | 10638 | 0.060 |
Why?
|
Eye Proteins | 1 | 2007 | 646 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2013 | 5078 | 0.060 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 132 | 0.060 |
Why?
|
Erythrocyte Count | 1 | 2003 | 163 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7722 | 0.060 |
Why?
|
CD40 Ligand | 2 | 2002 | 526 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2007 | 1663 | 0.050 |
Why?
|
Ca(2+) Mg(2+)-ATPase | 1 | 2002 | 14 | 0.050 |
Why?
|
HIV-1 | 1 | 2020 | 6939 | 0.050 |
Why?
|
Globins | 1 | 2003 | 415 | 0.050 |
Why?
|
Phenotype | 3 | 2016 | 16365 | 0.050 |
Why?
|
Biotinylation | 1 | 2002 | 179 | 0.050 |
Why?
|
Cambodia | 1 | 2022 | 191 | 0.050 |
Why?
|
Child, Preschool | 6 | 2023 | 41006 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2018 | 9734 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2538 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 343 | 0.050 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.050 |
Why?
|
Membrane Lipids | 1 | 2002 | 248 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4751 | 0.050 |
Why?
|
Hemoglobinopathies | 1 | 2001 | 96 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2001 | 253 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39050 | 0.040 |
Why?
|
Single-Cell Analysis | 2 | 2020 | 2183 | 0.040 |
Why?
|
Middle Aged | 4 | 2021 | 213383 | 0.040 |
Why?
|
Lymphoid Tissue | 1 | 2021 | 455 | 0.040 |
Why?
|
Antigens, Differentiation | 1 | 2002 | 927 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2021 | 229 | 0.040 |
Why?
|
gamma-Globins | 1 | 2019 | 95 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2023 | 739 | 0.040 |
Why?
|
Etoposide | 1 | 2019 | 641 | 0.040 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2017 | 29 | 0.040 |
Why?
|
Blood Buffy Coat | 1 | 2016 | 11 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 892 | 0.040 |
Why?
|
HIV Infections | 2 | 2020 | 16718 | 0.040 |
Why?
|
Infant | 4 | 2023 | 35136 | 0.040 |
Why?
|
Vidarabine | 1 | 2018 | 345 | 0.040 |
Why?
|
Intestine, Small | 1 | 2023 | 1241 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2020 | 648 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2021 | 1100 | 0.040 |
Why?
|
K562 Cells | 1 | 2018 | 634 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2019 | 913 | 0.030 |
Why?
|
Whole-Body Irradiation | 1 | 2016 | 449 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2007 | 3474 | 0.030 |
Why?
|
Radiation Chimera | 2 | 2008 | 223 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2019 | 1547 | 0.030 |
Why?
|
Dyskeratosis Congenita | 1 | 2015 | 72 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1072 | 0.030 |
Why?
|
Fever | 1 | 2022 | 1616 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 2015 | 143 | 0.030 |
Why?
|
Fetal Blood | 1 | 2021 | 1318 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2003 | 2072 | 0.030 |
Why?
|
Mice, Inbred C3H | 2 | 2008 | 964 | 0.030 |
Why?
|
Anemia, Aplastic | 1 | 2015 | 226 | 0.030 |
Why?
|
Cell Survival | 1 | 2003 | 5882 | 0.030 |
Why?
|
Glutamine | 1 | 2016 | 578 | 0.030 |
Why?
|
Bone Marrow | 1 | 2003 | 2948 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6473 | 0.030 |
Why?
|
Fanconi Anemia | 1 | 2015 | 319 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 827 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1878 | 0.030 |
Why?
|
Colon | 1 | 2020 | 1772 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9583 | 0.030 |
Why?
|
Dogs | 1 | 2016 | 3912 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2020 | 21746 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 25043 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2022 | 3798 | 0.020 |
Why?
|
Recurrence | 1 | 2023 | 8340 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1275 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77449 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2019 | 3420 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3206 | 0.020 |
Why?
|
Cell Line | 2 | 2020 | 15997 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2020 | 3036 | 0.020 |
Why?
|
Influenza, Human | 1 | 2020 | 1479 | 0.020 |
Why?
|
Lymphoma | 1 | 2017 | 1877 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2018 | 63114 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3200 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 1912 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1622 | 0.020 |
Why?
|
Immunization | 1 | 2011 | 1256 | 0.020 |
Why?
|
Virus Replication | 1 | 2014 | 2534 | 0.020 |
Why?
|
Kidney | 1 | 2002 | 7186 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2007 | 349 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2007 | 537 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29063 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7913 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1294 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9239 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8436 | 0.020 |
Why?
|
Oxygen | 1 | 2016 | 4189 | 0.020 |
Why?
|
Glucose | 1 | 2016 | 4397 | 0.010 |
Why?
|
Disease Management | 1 | 2014 | 2459 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2007 | 1537 | 0.010 |
Why?
|
Cholecalciferol | 1 | 2007 | 537 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8324 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.010 |
Why?
|
Titrimetry | 1 | 2001 | 36 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2007 | 1200 | 0.010 |
Why?
|
Clonal Deletion | 1 | 2001 | 79 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16689 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9856 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2001 | 425 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4568 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9727 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8863 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2008 | 2958 | 0.010 |
Why?
|
Mice, SCID | 1 | 2001 | 2716 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13695 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72290 | 0.010 |
Why?
|
Macrophages | 1 | 2007 | 5655 | 0.010 |
Why?
|